RIO DE JANEIRO, BRAZIL - AstraZeneca said on Monday, November 23rd, its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, the latest drugmaker to unveil positive interim data in a scientific race to curb a global pandemic.
The vaccine developed by Oxford University was 90% effective in preventing COVID-19 when it was administered as a half dose followed by a full dose at least one month apart, according to data from the late-stage trials in Britain and Brazil.
No serious safety events related to the vaccine have been confirmed and it was . . .